Heart Failure

The SGLT2 inhibitor empagliflozin improved CV and renal outcomes in patients with HF with reduced ejection fraction, regardless of diabetes status, according to results of the EMPEROR-Reduced trial.

Preeclampsia was associated with a twofold increased risk for HF, but gestational hypertension was not, according to a study of Norwegian women published in Hypertension.

More than 2% of the U.S. Medicare population has hyperkalemia, with a higher prevalence among adults with chronic kidney disease or heart failure, according to a study published in Current Medical Research and Opinion.

Nearly 12% of adults hospitalized for influenza also had an acute cardiovascular event, data show.

The increased risks for cardiovascular disease conferred by diabetes are greater for women than for men, but the newer diabetes drug classes reduce those risks similarly for both sexes, according to a speaker.

SGLT2 inhibitors reduce HF in patients with atherosclerotic CVD or risk factors regardless of diabetes status, but more data are needed particularly in HF with preserved ejection fraction, according to a speaker.

Patients diagnosed with sarcoidosis experienced greater risk for HF and other adverse CV outcomes compared with the general population, according to a study published in the Journal of the American College of Cardiology.

Researchers have found that women with peripheral artery disease were more likely to present with depressive symptoms than men, worsening their health status.

Association between calorie intake and post-discharge outcomes in patients hospitalized for HF.

Smaller pupil area measured in patients with acute HF was predictive of all-cause mortality and HF readmission, according to research published in ECS Heart Failure.